JAMA Neurology (Journal)
Researchers: Improving Eyesight May Help Prevent Dementia
Dementia cases are climbing along with an aging world population, and yet another much-anticipated Alzheimer’s medication, crenezumab, has proved ineffective in clinical trials — the latest of many disappointments. Public health experts and researchers argue that it is past time to turn our attention to a different approach — focusing on eliminating a dozen or […]
Know More
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drug
Safety data from those trials was published Monday in the journal JAMA Neurology in a study whose authors included eight Biogen employees. The data showed that 425 of 1,029 patients, or 41 percent, who received the high dose of the drug — the dose that the F.D.A. later approved — experienced either brain swelling or […]
Know More